ArticleVaccines2024

PREVAX: A Phase I Clinical Trial of an EGF-Based Vaccine in Moderate-to-Severe COPD Patients.

Jenysbel de la C Hernandez Reyes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.